Robert Schingler
Internal Medicine · Los Osos, CANPI 1821037615
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 98.6% of the total across 324 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 28 manufacturers, the largest accounting for just 14.1% — the pattern of someone who eats at a lot of different presentations. Reporting peaked in 2021 at $1,992 and has fallen 79.8% since, to $403 in 2022. Among internal medicine clinicians in CA with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 324 payments — averaging $16.64 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Amgen$760
- AbbVie$638
- Pfizer$608
- GSK$555
- Johnson & Johnson$459
- Novo Nordisk$436
- plus $2K from 22 others
What the payments were for
- Food & beverage$5,31699%
- Education$751%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Amgen | 42 | $760 |
| AbbVie(2 entities) | 37 | $638 |
| Pfizer | 34 | $608 |
| GSK | 49 | $555 |
| Johnson & Johnson | 26 | $459 |
| Novo Nordisk | 36 | $436 |
| Mylan Specialty L.p. | 12 | $275 |
| AstraZeneca | 12 | $200 |
| Boehringer Ingelheim | 10 | $196 |
| Astellas Pharma US Inc | 6 | $180 |
| Merck | 9 | $151 |
| Sanofi-aventis U.S. LLC | 9 | $150 |
| Lilly USA, LLC | 8 | $147 |
| Biohaven Pharmaceuticals, Inc. | 9 | $138 |
| Amarin Pharma, Inc. | 5 | $100 |
| Nestle Healthcare Nutrition Inc. | 4 | $72 |
| Eisai Inc. | 3 | $60 |
| Daiichi Sankyo Inc. | 2 | $43 |
| Therapeuticsmd, Inc. | 2 | $36 |
| Biohaven Pharmaceutical Holding Company Ltd. | 1 | $26 |
| Bayer | 1 | $26 |
| Sanofi Pasteur Inc. | 1 | $24 |
| Almatica Pharma LLC | 1 | $22 |
| Teva Pharmaceuticals USA, Inc. | 1 | $21 |
| Vifor Pharma, Inc. | 1 | $21 |
| Advanced Respiratory, Inc | 1 | $18 |
| Takeda Pharmaceuticals U.S.A., Inc. | 1 | $16 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 1 | $13 |
How this compares
$5,391 in reported general payments places this provider in the 90th percentile of 13,581 internal medicine providers in California.
Other internal medicine in Los Osos
- Andrew ChengSouth San Francisco$55.1M
- Tung NgoNewport Beach$4.9M
- Christian EversullStanford$2.9M
- Christian SandrockSacramento$2.1M
- Hatim HusainSan Diego$2M
- Teck LingPalo Alto$1.1M
- Hyong Kimla Jolla$1M
- Rohit Loombala Jolla$965K
- Fred CohenSan Francisco$929K
- Steven EdelmanSan Diego$863K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.